Investment Analysts’ Weekly Ratings Changes for Omada Health (OMDA)

Several analysts have recently updated their ratings and price targets for Omada Health (NASDAQ: OMDA):

• 4/14/2026 – Omada Health is now covered by Citigroup Inc.. They set an “outperform” rating on the stock.
• 4/14/2026 – Omada Health is now covered by Citizens Jmp. They set an “outperform” rating and a $18.00 price target on the stock.
• 4/9/2026 – Omada Health had its price target lowered by The Goldman Sachs Group, Inc. from $26.00 to $23.00. They now have a “buy” rating on the stock.
• 4/8/2026 – Omada Health had its “outperform” rating reaffirmed by Evercore Inc. They now have a $15.00 price target on the stock.
• 3/14/2026 – Omada Health was upgraded by Wall Street Zen from “hold” to “buy”.
• 3/12/2026 – Omada Health had its price target lowered by JPMorgan Chase & Co. from $32.00 to $26.00. They now have an “overweight” rating on the stock.
• 3/6/2026 – Omada Health had its price target lowered by Canaccord Genuity Group Inc. from $28.00 to $22.00. They now have a “buy” rating on the stock.
• 3/6/2026 – Omada Health had its price target lowered by BMO Capital Markets from $27.00 to $18.00. They now have an “outperform” rating on the stock.
• 3/6/2026 – Omada Health had its price target lowered by Morgan Stanley from $32.00 to $30.00. They now have an “overweight” rating on the stock.
• 3/3/2026 – Omada Health had its price target lowered by Barclays PLC from $22.00 to $17.00. They now have an “overweight” rating on the stock.

Insider Transactions at Omada Health

In other Omada Health news, CEO Sean P. Duffy sold 4,063 shares of the company’s stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $14.34, for a total value of $58,263.42. Following the completion of the transaction, the chief executive officer owned 117,598 shares of the company’s stock, valued at $1,686,355.32. This represents a 3.34% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, President Wei-Li Shao sold 2,829 shares of the company’s stock in a transaction dated Wednesday, April 8th. The stock was sold at an average price of $12.71, for a total value of $35,956.59. Following the completion of the transaction, the president directly owned 328,850 shares of the company’s stock, valued at approximately $4,179,683.50. The trade was a 0.85% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 8,776 shares of company stock valued at $120,483.

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.